The inability to recover intracellular ATP levels after a stress in obesity may explain the predisposition to liver injury in the obese caused by ischemia-reperfusion, for example donor liver ...

NAFLD is a chronic liver disease caused by fat buildup in the liver, even with little to no alcohol use. Risk factors for NAFLD include being overweight or obese, having type 2 diabetes, high ...

Fatty liver disease, including non‑alcoholic fatty liver disease (NAFLD) or metabolic dysfunction‑associated steatotic liver disease (MASLD), occurs when fat accumulates in liver cells, often without ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic dysfunction-associated non-alcoholic fatty liver disease has become the most prevalent chronic ...

MASH is the new term for NASH. MASH stands for metabolic dysfunction–associated steatohepatitis, a type of liver disease. The liver disease used to be referred to as non-alcoholic steatohepatitis, or ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

Obesity is linked to a lot of issues that can impact your health and quality of life. One of these is a condition called fatty liver disease. Fatty liver disease is an illness in which fat builds up ...

Several comorbidities are associated with nonalcoholic fatty liver disease, including cardiovascular disease, type 2 diabetes, and sleep apnea. Comorbidities refer to having two or more coexisting ...

Nonalcoholic fatty liver disease (NAFLD) can be reversed with several lifestyle changes, including diet and physical activity. NAFLD is a condition where fat builds up around the liver and is common ...

MADRID — Individuals with type 2 diabetes and/or obesity plus one or more metabolic risk factors are at a higher risk for metabolic dysfunction–associated steatotic liver disease (MASLD) with fibrosis ...